BBL
ETNB

Beck Bode LLC’s 89bio ETNB Stock Holding History

Beck Bode LLC’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,815,524
Closed -$13.2M – 110
2025
Q1 		$13.2M Buy
+1,815,524
New +$15.9M 2.46% 24

Other funds holding ETNB

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Beck Bode LLC's ETNB Position: Q2 2025 in Review

Beck Bode LLC sold out of 89bio (ETNB) in Q2 2025, closing a stake of 1,815,524 shares — an estimated $13.2M sold.

Beck Bode LLC first reported a position in ETNB in Q1 2025 and held it in 1 quarter. The position peaked at $13.2M in Q1 2025. 184 funds tracked by Wall St. Rank hold ETNB as of Q2 2025.

  • Beck Bode LLC reported no remaining 89bio position as of Q2 2025 after selling out during the quarter.
  • Beck Bode LLC sold 1,815,524 89bio shares in Q2 2025, an estimated $13.2M.
  • Beck Bode LLC first reported a position in 89bio in Q1 2025 and held it in 1 quarter.
  • Beck Bode LLC's 89bio position peaked at $13.2M in Q1 2025.
  • 184 funds tracked by Wall St. Rank held 89bio as of Q2 2025.

Based on Beck Bode LLC's 13F filing for Q2 2025, filed 8 Aug 2025.